Symphony of nanomaterials and immunotherapy based on the cancer–immunity cycle-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Symphony of nanomaterials and immunotherapy based on the cancer–immunity cycle

Published:2022-01 Issue:1 Volume:12 Page:107-134
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Li Qianqian^ORCID,Shi Zhaoqing^ORCID,Zhang Fan,Zeng Weiwei,Zhu Dunwan,Mei Lin^ORCID

Funder

Science, Technology and Innovation Commission of Shenzhen Municipality

Fundamental Research Funds for the Central Universities

China Postdoctoral Science Foundation

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference219 articles.

1. Cancer statistics, 2019;Siegel;Ca - Cancer J Clin,2019

2. Emerging nanomedicine approaches fighting tumor metastasis: animal models, metastasis-targeted drug delivery, phototherapy, and immunotherapy;Liang;Chem Soc Rev,2016

3. Cancer immunotherapy comes of age;Mellman;Nature,2011

4. The blockade of immune checkpoints in cancer immunotherapy;Pardoll;Nat Rev Cancer,2012

5. The future of immune checkpoint therapy;Sharma;Science,2015

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Magnetic and pH dual responsive injectable magnetic zeolitic imidazole framework based colloidal gel for interventional treatment on hepatocellular carcinoma;Chemical Engineering Journal;2024-10

2. Innovative hydrogel-based delivery systems for immunotherapy: A review of pre-clinical progress;Nano Research;2024-09-12

3. Clinical translation of nanomedicine with integrated digital medicine and machine learning interventions;Colloids and Surfaces B: Biointerfaces;2024-09

4. In situ tumor vaccine with optimized nanoadjuvants and lymph node targeting capacity to treat ovarian cancer and metastases;Acta Pharmaceutica Sinica B;2024-09

5. Enhancing cancer immunotherapy: Nanotechnology-mediated immunotherapy overcoming immunosuppression;Acta Pharmaceutica Sinica B;2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3